NYSEAMERICAN:SENS - Senseonics Stock Price, Forecast & News

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics Holdings Inc (NYSEAMERICAN:SENS) released its quarterly earnings data on Wednesday, August, 8th. The company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by $0.09. The company had revenue of $3.62 million for the quarter, compared to analyst estimates of $3.87 million. The company's quarterly revenue was up 345.1% compared to the same quarter last year. During the same period last year, the company earned ($0.12) EPS. View Senseonics' Earnings History.

Senseonics is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Senseonics.

6 brokerages have issued 12 month price targets for Senseonics' stock. Their forecasts range from $1.00 to $2.50. On average, they anticipate Senseonics' share price to reach $1.90 in the next twelve months. This suggests a possible upside of 37.7% from the stock's current price. View Analyst Price Targets for Senseonics.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Senseonics.

Media coverage about SENS stock has trended very negative this week, InfoTrie reports. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Senseonics earned a news impact score of -3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Senseonics.

Senseonics saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 37,420,000 shares, an increase of 6.6% from the January 30th total of 35,100,000 shares. Based on an average daily volume of 1,360,000 shares, the days-to-cover ratio is currently 27.5 days. Currently, 36.5% of the shares of the stock are sold short. View Senseonics' Current Options Chain.

Some companies that are related to Senseonics include Integral Diagnostics (IDX), Akumin (AKU), Profound Medical (PRN), Volpara Health Tech (VHT), Exagen (XGN), Renalytix Ai (RENX), Palatin Technologies (PTN), MaxCyte (MXCT), Yourgene Health (YGEN), Oncosil Medical (OSL), Lexagene (LXG), BARD1 Life Sciences (BD1), Oncimmune (ONC), Sernova (SVA) and GeneNews (GEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include Agile Therapeutics (AGRX), Tandem Diabetes Care (TNDM), VirnetX (VHC), Nabriva Therapeutics (NBRV), Advanced Micro Devices (AMD), Melinta Therapeutics (MLNT), Micron Technology (MU), Sorrento Therapeutics (SRNE), vTv Therapeutics (VTVT) and Vaxart (VXRT).

Senseonics' stock is owned by a number of of retail and institutional investors. Top institutional investors include Delphi Management Partners VIII L.L.C. (4.84%), Silverback Asset Management LLC (1.34%), State Street Corp (0.91%), Geode Capital Management LLC (0.83%), Raymond James & Associates (0.52%) and Raymond James Financial Services Advisors Inc. (0.30%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View Institutional Ownership Trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, UBS Group AG, Bank of America Corp DE, Raymond James & Associates, Bank of New York Mellon Corp, Daiwa Securities Group Inc. and Raymond James Financial Services Advisors Inc.. View Insider Buying and Selling for Senseonics.

SENS stock was bought by a variety of institutional investors in the last quarter, including Delphi Management Partners VIII L.L.C., Virtu Financial LLC, Geode Capital Management LLC, Magnus Financial Group LLC, Spark Investment Management LLC, Palisade Capital Management LLC NJ, Trust Co. of Oklahoma and Goldman Sachs Group Inc.. View Insider Buying and Selling for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $1.38.

Senseonics has a market capitalization of $280.77 million. Senseonics employs 192 workers across the globe.View Additional Information About Senseonics.

The official website for Senseonics is http://www.senseonics.com/.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.